MaxCyte
NASDAQ: MXCT
$1.08
+0.01
(+0.93%)
as on
MaxCyte Stock Performance
as on October 6, 2026 at 2:16 pm IST
Day's Low
Day's High
$1.06$1.10
1.85%
Downside
1.85%
Upside
52 Week's Low
52 Week's High
$0.64$1.8740.43%
Downside
72.69%
Upside
MaxCyte share price movements today
- Previous Close
- $1.07
- Open
- $1.08
- Volume
- 311.7K
- Market Cap
- $110.4M
- Day's Low - High
- $1.06 - $1.10
- 52 Week Low - High
- $0.64 - $1.87
MaxCyte Historical Returns
- 1 Month Return
- -15.62 %
- 3 Month Return
- -14.96 %
- 1 Year Return
- -34.55 %
- 3 Year Return
- -62.24 %
- 5 Year Return
- -89.84 %
MaxCyte Stock Fundamentals & Key Indicators
Check MaxCyte market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$110.4M
EPS (TTM)
-0.3343
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-3.2
Industry PE ratio
-3.47
PEG Ratio
-0.12
EBITDA
-32.5M
Revenue (TTM)
31.1M
Profit Margin
79.43%
Return On Equity TTM
-21.01%
MaxCyte vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of MaxCyte with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $110.4M | -89.84% | -3.20 | 79.43% | 0.00% | |
| Buy | $49.0B | -20.32% | 48.94 | 77.98% | 0.00% | |
| Buy | $110.5B | -30.23% | 21.12 | 66.69% | 3.31% | |
| StrongBuy | $105.6B | 8.15% | 28.31 | 65.17% | 1.28% | |
| StrongBuy | $168.7B | -14.07% | 31.35 | 56.80% | 2.54% |
Stock Returns calculator for MaxCyte Stock including INR - Dollar returns
The MaxCyte stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
MaxCyte investment value today
Current value as on today
₹71,135
Returns
Returns from MaxCyte Stock
Dollar Impact
₹5,680 (+5.68%)
Analyst Recommendation on MaxCyte Stock
Based on 3 analysts
66.67%
Buy
33.33%
Hold
0.00%
Sell
Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for MaxCyte. Average target price of $4.11
MaxCyte Share Price Target
Get share price movements and forecasts by analysts on MaxCyte.
What analysts predicted
73.72%UPSIDE
Target Price
$4.11
Current Price
$1.08
Analyzed by
3 Analysts
High
$4
Target
$4.11
Low
$4
MaxCyte target price $4.11, a slight upside of 73.72% compared to current price of $1.08. According to 3 analysts rating.
Indian Investors' Interest in MaxCyte Stock
Search interest for MaxCyte Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
MaxCyte Quarterly Profit & Loss
All numbers in Millions USD
MaxCyte Annual Profit & Loss
All numbers in Millions USD
MaxCyte Quarterly Cash Flow
All numbers in Millions USD
MaxCyte Annual Cash Flow
All numbers in Millions USD
Insights on MaxCyte
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Edwards Lifesciences Corp has given 18.4% return, outperforming this stock by 80.6%
- NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp has given 13.9% return, outperforming this stock by 48.4%
NEGATIVE IMPACTPrice Dip
In the last 7 days, MXCT stock has moved down by -8.5%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 9.65M → 7.27M (in $), with an average decrease of 24.7% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -4.75M → -8.87M (in $), with an average decrease of 86.8% per quarter
About MaxCyte
| Organisation | MaxCyte |
| Headquarters | 9713 Key West Avenue, Rockville, MD, 20850, US |
| Industry | Biotechnology |
| CEO | Maher Masoud |
Key Management of MaxCyte
Name | Title |
|---|---|
Ms. Jill Mayer | Senior Vice President of Human Resources |
Mr. Maher Masoud | President, CEO & Executive Director |
Mr. Parmeet Ahuja | Chief Financial Officer |
Mr. Jay Gelfman | Chief Operations Officer |
Ms. Ana-Paula Martins Fernandes | Senior Vice President of Global Sales |
Mr. Sidharth Kapileshwar | Chief Corporate Development Officer |
FAQs
What is MaxCyte share price today?
MaxCyte share price today is $1.08 as on at the close of the market. MaxCyte share today touched a day high of $1.10 and a low of $1.06.
What is the 52 week high and 52 week low for MaxCyte share?
MaxCyte share touched a 52 week high of $1.87 on and a 52 week low of $0.64 on . MaxCyte stock price today i.e. is closed at $1.08,which is 42.09% down from its 52 week high and 67.86% up from its 52 week low.
What is MaxCyte's market capitalisation today?
MaxCyte market capitalisation is $0.00T as on .
How to invest in MaxCyte Stock (MXCT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for MaxCyte on INDmoney app. Click on Buy button.
What is the minimum amount required to buy MaxCyte Stock (MXCT) from India?
Indian investors can start investing in MaxCyte (MXCT) shares with as little as ₹96.419998168945 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹964.20 in MaxCyte stock (as per the Rupee-Dollar exchange rate as on ).
Based on MaxCyte share’s latest price of $1.08 as on October 6, 2026 at 8:46 am IST, you will get 9.2593 shares of MaxCyte. Learn more about
fractional shares .
What are the returns that MaxCyte has given to Indian investors in the last 5 years?
MaxCyte stock has given -89.84% share price returns and 29.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?